Skip to main content
HINOVA PHARMACEUTICALS INC. logo

HINOVA PHARMACEUTICALS INC. — Investor Relations & Filings

Ticker · 688302 ISIN · CNE1000059F5 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2026-04-24 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688302

About HINOVA PHARMACEUTICALS INC.

https://www.hinovapharma.com/

Hinova Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of cancers and metabolic diseases. The company leverages its core technology platforms, including targeted protein degradation (PROTAC) and deuterium-based drug discovery, to develop a diverse pipeline of small molecule therapeutics. Its lead candidate, HC-1119 (deuterenzalutamide), is a next-generation androgen receptor antagonist currently in late-stage clinical development for metastatic castration-resistant prostate cancer. Other key programs include HP518, an orally bioavailable PROTAC degrader targeting the androgen receptor, and HP501, a selective URAT1 inhibitor designed for the treatment of hyperuricemia and gout. Hinova aims to address significant unmet medical needs through the development of high-quality, differentiated therapies for global markets.

Recent filings

Filing Released Lang Actions
2025年非经营性资金占用及其他关联资金往来情况的专项审计报告
Audit Report / Information Classification · 95% confidence The document is a specialized audit report titled "专项审计报告" related to non-operating fund occupation and other related party fund transactions for the fiscal year 2025 of 海创药业股份有限公司. It includes detailed tables of fund occupation and related party transactions, and is issued by a certified public accounting firm 信永中和会计师事务所. The document contains audit opinions, reconciliations with the audited financial statements, and is a standalone audit report focusing on a specific aspect of the company's financials, not a full annual report. It is not a mere announcement or certification but contains substantive audit content. Therefore, it fits the category of Audit Report / Information (AR). FY 2025
2026-04-24 Chinese
关于使用部分暂时闲置自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by the company 海创药业股份有限公司 regarding the use of temporarily idle own funds for cash management. It details the investment amount, types of investment products, risk control measures, and the board's approval of the plan. The document is relatively short (1819 characters) and does not contain any financial statements or detailed financial data. It is an announcement about a financing or capital management activity rather than a full financial report or audit. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2026-04-24 Chinese
2025年度独立董事述职报告（彭永臣）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2025 Annual Work Report" for a company. It details the independent director's background, attendance at board and shareholder meetings, committee participation, communication with auditors, and other governance-related activities during the year 2025. It also discusses the director's evaluation of company governance, internal controls, and compliance with laws and regulations. The document is a detailed report on the independent director's annual duties and performance rather than a general annual report, audit report, or other financial filings. This fits the category of Board/Management Information (MANG), which includes announcements or reports related to changes or activities of the company's board or senior management. The document is not a financial report, earnings release, or regulatory filing, but a specific annual report by an independent director on their work and observations.
2026-04-24 Chinese
关于部分首次公开发行股票募集资金专户销户完成的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of the closure of certain special accounts for funds raised from the company's initial public offering (IPO). It details the management and regulatory compliance of the raised funds, the bank accounts involved, and the formal closure of some of these accounts. There is no financial statement, audit report, or detailed financial data presented. The document is a formal announcement about the status of fundraising accounts, not a report or detailed financial disclosure. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2026-04-24 Chinese
2025年度内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report'. It is issued by a certified public accounting firm (ShineWing) and addresses the effectiveness of internal control over financial reporting for the fiscal year ending December 31, 2025. The content includes auditor responsibilities, management responsibilities, and an audit opinion on internal control effectiveness. The document is 3266 characters long, which is relatively short but contains the full audit report text rather than just an announcement or certification. This matches the description of an Audit Report / Information (AR) as it is a standalone audit report focusing on internal control over financial reporting, not a full annual report or other filing type. Therefore, the correct classification is AR with high confidence. FY 2025
2026-04-24 Chinese
关于2025年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the company's 2025 profit distribution plan, stating no cash dividends, no stock dividends, and no capital reserve conversion to shares. It mentions the board's approval and that the plan will be submitted to the annual shareholders' meeting for approval. The document is short (1133 characters) and primarily serves as a formal announcement of the profit distribution proposal rather than the distribution itself or a detailed financial report. This fits the definition of a Notice of Dividend Amount (DIV) as it relates to dividend distribution plans and shareholder information about dividends.
2026-04-24 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.